Scholar Rock

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGFß) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for development of monoclonal antibodies that locally and selectively target the precursor.

Morgan Prestwich were successfully retained by the Scholar Rock leadership to appoint their SVP Head of International, to be based out of their European headquarters in Zug Switzerland. Morgan Prestwich shortlisted an exceptional list of experienced candidates, after initial interviews Scholar Rock took 3 candidates to their Boston offices for an intense 2 day interview process. Morgan Prestwich are exclusive partner to build the rest of Europe.

International:
- SVP General Manager International (Zug, Switzerland)
- Wider leadership & country build-out is ongoing.